Working with its clients to ensure a successful outcome in terms of market access, Grove consultants provide expert advice in three key areas:
The Armenian healthcare sector remains somewhat underdeveloped in comparison to others within the Central and Eastern European region. Although legislation has been agreed to provide for the reimbursement policy, getting from paper to practical implementation has been less than optimal and as a result access to medicines remains a critical issue for much of the population.
Given high levels of out-of-pocket medicine purchases, this is an area which is receiving considerable attention and one where we are likely to see regulatory developments in the future.
As in other areas, the Ministry of Health and the Scientific Centre of Drug and Medical Technology Expertise (SCDMTE) as an agency within the Ministry of Health, play a key role in the market for medicines, medical devices, food supplements and cosmetics.
The still embryonic local regulatory affairs environment requires very careful navigation. In a market where the government continues to struggle to implement any policy for managing prices of pharmaceuticals, if new market entrants are to get their own pricing and reimbursement strategies right, local market knowledge is key.
With experienced local consultants, Grove can assist with: